8-K - Alaunos Therapeutics, Inc. | StockGist

Current Report Details

Event Type

Material Agreement

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

1.01

Entry into a Material Definitive Agreement On December 17, 2025, Alaunos Therapeutics, Inc. (the “Company”) entered into a Settlement and Release Agreement (the

Material Agreement

$285.1K$142.5K$28.5K$28.5K

Source Document

9.01

Financial Statements and Exhibits (d) Exhibits. Exhibit No. Description 10.1 Settlement Agreement, dated December 17, 2025 SIGNATURES Pursuant to the requiremen

Exhibits Only

Exhibits (2)

10.1

EX-10.1

8-K